Postanesthesia Care

Latest Issue of OR Manager
July 2025
Home Postanesthesia Care

Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery

JAMA (healthcare publication) Network logo

Editor's Note Older surgical patients with preoperative cognitive impairment face significantly higher odds of developing postoperative delirium (POD), and POD itself is tied to markedly worse surgical outcomes, according to two major studies published July 2025. Together, the findings point to delirium as both a high-impact and potentially modifiable target…

Read More

By: Tarsilla Moura
August 14, 2025
Share

Major study clarifies risks, severity of perioperative pulmonary aspiration

Editor's Note Preliminary results from a nearly million-case review reveal that perioperative pulmonary aspiration, while feared, is rare but potentially deadly. According to a February 4 Anesthesiology News report, researchers found an overall incidence of 1 in 5,572 anesthesia cases, with aspiration-related mortality at about 1 in 67,000. As detailed…

Read More

By: Tarsilla Moura
August 11, 2025
Share

OR Manager Conference spotlights ASC, PACU leadership with poster presentations, awards

Editor's Note This fall, the OR Manager Conference will bring outpatient and postanesthesia care innovation to the forefront with its dual spotlight on poster presentations and leadership awards. Both initiatives emphasize the evolving needs and accomplishments of perioperative teams in ambulatory surgery centers (ASCs) and postanesthesia care units (PACUs), offering…

Read More

By: Tarsilla Moura
July 9, 2025
Share

New AAAHC toolkit advances pain control while cutting opioid use in outpatient surgery

Editor's Note The Accreditation Association for Ambulatory Health Care (AAAHC) launched a new pain management toolkit that prioritizes multimodal strategies to improve outcomes and reduce opioid use in ambulatory surgery. Designed for the unique challenges of outpatient care, the resource provides practical, evidence-based guidance to optimize safety, comfort, and recovery.…

Read More

By: Tarsilla Moura
July 9, 2025
Share

Sponsored Message

Neuromodulation gaining momentum as a transformative force in neuro care

Editor's Note Neuromodulation is shifting from the margins to the forefront of neurological treatment, offering real-world potential to transform care for conditions like epilepsy, Parkinson’s disease, and substance use disorder. As reported by Medical Device Network on May 19, the field is seeing accelerated innovation and investment, with global market…

Read More

By: Tarsilla Moura
July 1, 2025
Share

Deadline extended for OR Manager Awards nominations

Editor's Note The nomination deadline for the 2025 OR Manager Awards has been extended to July 30, providing extra time to recognize the perioperative leaders who inspire you most.  Each year, the OR Manager of the Year, PACU Leader of the Year, and Ambulatory Nurse Leader of the Year are…

Read More

By: Matt Danford
June 27, 2025
Share

Sponsored Message

Last call for OR Manager Award nominations

Editor's Note Do you know a perioperative leader who deserves to be honored before their peers at a gathering of virtually the entire industry? This is just one way we honor the recipients of our annual OR Manager Awards—OR Manager of the Year, PACU Leader of the Year, and Ambulatory…

Read More

By: Matt Danford
June 20, 2025
Share

Continuum-based protocol offers new strategy for preventing PONV after thyroidectomy

Editor's Note Postoperative nausea and vomiting (PONV) remain a significant concern in thyroidectomy patients, with incidence rates reaching up to 80% in high-risk groups, Medical Dialogues April 25 reports. Despite effective intraoperative and postanesthesia care unit (PACU) protocols, gaps often arise during patient transitions to wards or intensive care units,…

Read More

By: Tarsilla Moura
April 30, 2025
Share

Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows

Editor's Note According to results from a randomized trial, titled KEYNOTE-689, adding pembrolizumab (Keytruda) to surgery and standard adjuvant therapy significantly prolongs event-free survival (EFS) in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC), MedPage Today April 28 reports. Experts are calling the findings a major…

Read More

By: Tarsilla Moura
April 29, 2025
Share

Subarachnoid spinal anesthesia offers safe, effective option for high-risk obstetric patients

Editor's Note Segmental spinal anesthesia (SSA) has emerged as a safe and effective anesthetic technique for high-risk obstetric patients, particularly those with underlying cardiovascular disease (CVD). A recent case series published on April 29 by Medical Dialogues highlights the successful use of SSA in five parturients undergoing cesarean sections, emphasizing…

Read More

By: Tarsilla Moura
April 29, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat